CA9-derived peptide vaccines (Kinki University)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCA9-derived peptide vaccines (Kinki University)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Synthetic peptide vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCarcinoma, Renal Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesKindai University

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesKindai University

Active IndicationsN/A

Inactive IndicationsCarcinoma, Renal Cell

ATC CodeN/A